Dynavax Technologies Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results and Launched a $200 Million Share Buyback Program. HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
Dynavax Technologies Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results and Launched a $200 Million Share Buyback Program. HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
德納維製藥股價上漲,該公司公佈了優於預期的第三季度每股收益結果,並啓動了20000萬美元的股票回購計劃。瑞士信貸重申該股的買入評級。
Dynavax Technologies Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results and Launched a $200 Million Share Buyback Program. HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
德納維製藥股價上漲,該公司公佈了優於預期的第三季度每股收益結果,並啓動了20000萬美元的股票回購計劃。瑞士信貸重申該股的買入評級。